Cetera Investment Advisers’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-8,674
Closed -$687K 3727
2024
Q1
$687K Buy
8,674
+1,042
+14% +$85.2K ﹤0.01% 2364
2023
Q4
$593K Buy
7,632
+10
+0.1% +$740 ﹤0.01% 1400
2023
Q3
$536K Sell
7,622
-273
-3% -$20.4K ﹤0.01% 1382
2023
Q2
$629K Sell
7,895
-144
-2% -$10.4K 0.01% 1308
2023
Q1
$581K Sell
8,039
-5,623
-41% -$438K 0.01% 1344
2022
Q4
$1.12M Buy
13,662
+9,166
+204% +$756K 0.01% 946
2022
Q3
$351K Buy
+4,496
New +$359K 0.01% 1179
2021
Q4
Sell
-5,148
Closed -$328K 1853
2021
Q3
$328K Buy
5,148
+140
+3% +$8.84K 0.01% 1380
2021
Q2
$314K Buy
+5,008
New +$314K 0.01% 1384

Other funds holding ACHC

Cetera Investment Advisers's ACHC Position: Q2 2024 in Review

Cetera Investment Advisers sold out of Acadia Healthcare (ACHC) in Q2 2024, closing a stake of 8,674 shares — an estimated $687K sold.

Cetera Investment Advisers first reported a position in ACHC in Q2 2021 and held it in 9 quarters. The position peaked at $1.12M in Q4 2022. 305 funds tracked by Wall St. Rank hold ACHC as of Q2 2024.

  • Cetera Investment Advisers reported no remaining Acadia Healthcare position as of Q2 2024 after selling out during the quarter.
  • Cetera Investment Advisers sold 8,674 Acadia Healthcare shares in Q2 2024, an estimated $687K.
  • Cetera Investment Advisers first reported a position in Acadia Healthcare in Q2 2021 and held it in 9 quarters.
  • Cetera Investment Advisers's Acadia Healthcare position peaked at $1.12M in Q4 2022.
  • 305 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2024.

Based on Cetera Investment Advisers's 13F filing for Q2 2024, filed 22 Aug 2024.